Global Oncology/Cancer Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Oncology/Cancer Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncology/Cancer Drugs market are covered in Chapter 9:
F. Hoffmann-La Roche Ltd.
AstraZeneca PLC
Merck & Co., Inc.
Amgen
Novartis AG
Astellas Pharma Inc.
Pfizer Inc.
AbbVie Inc.
Johnson & Johnson (Janssen Global Services, LLC)
Bristol-Myers Squibb Company
In Chapter 5 and Chapter 7.3, based on types, the Oncology/Cancer Drugs market from 2017 to 2027 is primarily split into:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
In Chapter 6 and Chapter 7.4, based on applications, the Oncology/Cancer Drugs market from 2017 to 2027 covers:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncology/Cancer Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncology/Cancer Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncology/Cancer Drugs market are covered in Chapter 9:
F. Hoffmann-La Roche Ltd.
AstraZeneca PLC
Merck & Co., Inc.
Amgen
Novartis AG
Astellas Pharma Inc.
Pfizer Inc.
AbbVie Inc.
Johnson & Johnson (Janssen Global Services, LLC)
Bristol-Myers Squibb Company
In Chapter 5 and Chapter 7.3, based on types, the Oncology/Cancer Drugs market from 2017 to 2027 is primarily split into:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
In Chapter 6 and Chapter 7.4, based on applications, the Oncology/Cancer Drugs market from 2017 to 2027 covers:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncology/Cancer Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncology/Cancer Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ONCOLOGY/CANCER DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology/Cancer Drugs Market
1.2 Oncology/Cancer Drugs Market Segment by Type
1.2.1 Global Oncology/Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology/Cancer Drugs Market Segment by Application
1.3.1 Oncology/Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology/Cancer Drugs Market, Region Wise (2017-2027)
1.4.1 Global Oncology/Cancer Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.4 China Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.6 India Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology/Cancer Drugs (2017-2027)
1.5.1 Global Oncology/Cancer Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology/Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology/Cancer Drugs Market
2 INDUSTRY OUTLOOK
2.1 Oncology/Cancer Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology/Cancer Drugs Market Drivers Analysis
2.4 Oncology/Cancer Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology/Cancer Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology/Cancer Drugs Industry Development
3 GLOBAL ONCOLOGY/CANCER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology/Cancer Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology/Cancer Drugs Average Price by Player (2017-2022)
3.4 Global Oncology/Cancer Drugs Gross Margin by Player (2017-2022)
3.5 Oncology/Cancer Drugs Market Competitive Situation and Trends
3.5.1 Oncology/Cancer Drugs Market Concentration Rate
3.5.2 Oncology/Cancer Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY/CANCER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology/Cancer Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology/Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology/Cancer Drugs Market Under COVID-19
4.5 Europe Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology/Cancer Drugs Market Under COVID-19
4.6 China Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology/Cancer Drugs Market Under COVID-19
4.7 Japan Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology/Cancer Drugs Market Under COVID-19
4.8 India Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology/Cancer Drugs Market Under COVID-19
4.9 Southeast Asia Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology/Cancer Drugs Market Under COVID-19
4.10 Latin America Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology/Cancer Drugs Market Under COVID-19
4.11 Middle East and Africa Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology/Cancer Drugs Market Under COVID-19
5 GLOBAL ONCOLOGY/CANCER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology/Cancer Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology/Cancer Drugs Price by Type (2017-2022)
5.4 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Chemotherapy (2017-2022)
5.4.2 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Targeted Therapy (2017-2022)
5.4.3 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
5.4.4 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Hormonal Therapy (2017-2022)
6 GLOBAL ONCOLOGY/CANCER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology/Cancer Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology/Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology/Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology/Cancer Drugs Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
6.3.2 Global Oncology/Cancer Drugs Consumption and Growth Rate of Retail Pharmacies (2017-2022)
6.3.3 Global Oncology/Cancer Drugs Consumption and Growth Rate of Online Pharmacies (2017-2022)
6.3.4 Global Oncology/Cancer Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ONCOLOGY/CANCER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Oncology/Cancer Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology/Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology/Cancer Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology/Cancer Drugs Price and Trend Forecast (2022-2027)
7.2 Global Oncology/Cancer Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology/Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology/Cancer Drugs Revenue and Growth Rate of Chemotherapy (2022-2027)
7.3.2 Global Oncology/Cancer Drugs Revenue and Growth Rate of Targeted Therapy (2022-2027)
7.3.3 Global Oncology/Cancer Drugs Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
7.3.4 Global Oncology/Cancer Drugs Revenue and Growth Rate of Hormonal Therapy (2022-2027)
7.4 Global Oncology/Cancer Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.4.2 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Retail Pharmacies(2022-2027)
7.4.3 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Online Pharmacies(2022-2027)
7.4.4 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Oncology/Cancer Drugs Market Forecast Under COVID-19
8 ONCOLOGY/CANCER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology/Cancer Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology/Cancer Drugs Analysis
8.6 Major Downstream Buyers of Oncology/Cancer Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology/Cancer Drugs Industry
9 PLAYERS PROFILES
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.1.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 AstraZeneca PLC
9.2.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.2.3 AstraZeneca PLC Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Merck & Co., Inc.
9.3.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.3.3 Merck & Co., Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Amgen
9.4.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.4.3 Amgen Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Astellas Pharma Inc.
9.6.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.6.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Pfizer Inc.
9.7.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.7.3 Pfizer Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 AbbVie Inc.
9.8.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.8.3 AbbVie Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Johnson & Johnson (Janssen Global Services, LLC)
9.9.1 Johnson & Johnson (Janssen Global Services, LLC) Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.9.3 Johnson & Johnson (Janssen Global Services, LLC) Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Bristol-Myers Squibb Company
9.10.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.10.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Oncology/Cancer Drugs Market
1.2 Oncology/Cancer Drugs Market Segment by Type
1.2.1 Global Oncology/Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncology/Cancer Drugs Market Segment by Application
1.3.1 Oncology/Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncology/Cancer Drugs Market, Region Wise (2017-2027)
1.4.1 Global Oncology/Cancer Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.4 China Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.6 India Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncology/Cancer Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncology/Cancer Drugs (2017-2027)
1.5.1 Global Oncology/Cancer Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncology/Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncology/Cancer Drugs Market
2 INDUSTRY OUTLOOK
2.1 Oncology/Cancer Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncology/Cancer Drugs Market Drivers Analysis
2.4 Oncology/Cancer Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncology/Cancer Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncology/Cancer Drugs Industry Development
3 GLOBAL ONCOLOGY/CANCER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Oncology/Cancer Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Oncology/Cancer Drugs Average Price by Player (2017-2022)
3.4 Global Oncology/Cancer Drugs Gross Margin by Player (2017-2022)
3.5 Oncology/Cancer Drugs Market Competitive Situation and Trends
3.5.1 Oncology/Cancer Drugs Market Concentration Rate
3.5.2 Oncology/Cancer Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLOGY/CANCER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncology/Cancer Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncology/Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncology/Cancer Drugs Market Under COVID-19
4.5 Europe Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncology/Cancer Drugs Market Under COVID-19
4.6 China Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncology/Cancer Drugs Market Under COVID-19
4.7 Japan Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncology/Cancer Drugs Market Under COVID-19
4.8 India Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncology/Cancer Drugs Market Under COVID-19
4.9 Southeast Asia Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncology/Cancer Drugs Market Under COVID-19
4.10 Latin America Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncology/Cancer Drugs Market Under COVID-19
4.11 Middle East and Africa Oncology/Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncology/Cancer Drugs Market Under COVID-19
5 GLOBAL ONCOLOGY/CANCER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncology/Cancer Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Oncology/Cancer Drugs Price by Type (2017-2022)
5.4 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Chemotherapy (2017-2022)
5.4.2 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Targeted Therapy (2017-2022)
5.4.3 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
5.4.4 Global Oncology/Cancer Drugs Sales Volume, Revenue and Growth Rate of Hormonal Therapy (2017-2022)
6 GLOBAL ONCOLOGY/CANCER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Oncology/Cancer Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Oncology/Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncology/Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncology/Cancer Drugs Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
6.3.2 Global Oncology/Cancer Drugs Consumption and Growth Rate of Retail Pharmacies (2017-2022)
6.3.3 Global Oncology/Cancer Drugs Consumption and Growth Rate of Online Pharmacies (2017-2022)
6.3.4 Global Oncology/Cancer Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ONCOLOGY/CANCER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Oncology/Cancer Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncology/Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncology/Cancer Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncology/Cancer Drugs Price and Trend Forecast (2022-2027)
7.2 Global Oncology/Cancer Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncology/Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncology/Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncology/Cancer Drugs Revenue and Growth Rate of Chemotherapy (2022-2027)
7.3.2 Global Oncology/Cancer Drugs Revenue and Growth Rate of Targeted Therapy (2022-2027)
7.3.3 Global Oncology/Cancer Drugs Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
7.3.4 Global Oncology/Cancer Drugs Revenue and Growth Rate of Hormonal Therapy (2022-2027)
7.4 Global Oncology/Cancer Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.4.2 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Retail Pharmacies(2022-2027)
7.4.3 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Online Pharmacies(2022-2027)
7.4.4 Global Oncology/Cancer Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Oncology/Cancer Drugs Market Forecast Under COVID-19
8 ONCOLOGY/CANCER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncology/Cancer Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncology/Cancer Drugs Analysis
8.6 Major Downstream Buyers of Oncology/Cancer Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncology/Cancer Drugs Industry
9 PLAYERS PROFILES
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.1.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 AstraZeneca PLC
9.2.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.2.3 AstraZeneca PLC Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Merck & Co., Inc.
9.3.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.3.3 Merck & Co., Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Amgen
9.4.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.4.3 Amgen Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Astellas Pharma Inc.
9.6.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.6.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Pfizer Inc.
9.7.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.7.3 Pfizer Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 AbbVie Inc.
9.8.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.8.3 AbbVie Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Johnson & Johnson (Janssen Global Services, LLC)
9.9.1 Johnson & Johnson (Janssen Global Services, LLC) Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.9.3 Johnson & Johnson (Janssen Global Services, LLC) Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Bristol-Myers Squibb Company
9.10.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncology/Cancer Drugs Product Profiles, Application and Specification
9.10.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Oncology/Cancer Drugs Product Picture
Table Global Oncology/Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology/Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology/Cancer Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology/Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology/Cancer Drugs Industry Development
Table Global Oncology/Cancer Drugs Sales Volume by Player (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Share by Player (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Share by Player in 2021
Table Oncology/Cancer Drugs Revenue (Million USD) by Player (2017-2022)
Table Oncology/Cancer Drugs Revenue Market Share by Player (2017-2022)
Table Oncology/Cancer Drugs Price by Player (2017-2022)
Table Oncology/Cancer Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology/Cancer Drugs Sales Volume, Region Wise (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Oncology/Cancer Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology/Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share, Region Wise in 2021
Table Global Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume by Type (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share by Type in 2021
Table Global Oncology/Cancer Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share by Type in 2021
Table Oncology/Cancer Drugs Price by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Chemotherapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Targeted Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Hormonal Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2017-2022)
Table Global Oncology/Cancer Drugs Consumption by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Market Share by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Retail Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Online Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology/Cancer Drugs Price and Trend Forecast (2022-2027)
Figure USA Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology/Cancer Drugs Market Sales Volume Forecast, by Type
Table Global Oncology/Cancer Drugs Sales Volume Market Share Forecast, by Type
Table Global Oncology/Cancer Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Oncology/Cancer Drugs Revenue Market Share Forecast, by Type
Table Global Oncology/Cancer Drugs Price Forecast, by Type
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2022-2027)
Table Global Oncology/Cancer Drugs Market Consumption Forecast, by Application
Table Global Oncology/Cancer Drugs Consumption Market Share Forecast, by Application
Table Global Oncology/Cancer Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Oncology/Cancer Drugs Revenue Market Share Forecast, by Application
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Retail Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Online Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Oncology/Cancer Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure AstraZeneca PLC Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc. Profile
Table AbbVie Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure AbbVie Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson (Janssen Global Services, LLC) Profile
Table Johnson & Johnson (Janssen Global Services, LLC) Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson (Janssen Global Services, LLC) Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson (Janssen Global Services, LLC) Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Figure Oncology/Cancer Drugs Product Picture
Table Global Oncology/Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Oncology/Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncology/Cancer Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncology/Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncology/Cancer Drugs Industry Development
Table Global Oncology/Cancer Drugs Sales Volume by Player (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Share by Player (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Share by Player in 2021
Table Oncology/Cancer Drugs Revenue (Million USD) by Player (2017-2022)
Table Oncology/Cancer Drugs Revenue Market Share by Player (2017-2022)
Table Oncology/Cancer Drugs Price by Player (2017-2022)
Table Oncology/Cancer Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology/Cancer Drugs Sales Volume, Region Wise (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Oncology/Cancer Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncology/Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share, Region Wise in 2021
Table Global Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume by Type (2017-2022)
Table Global Oncology/Cancer Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume Market Share by Type in 2021
Table Global Oncology/Cancer Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue Market Share by Type in 2021
Table Oncology/Cancer Drugs Price by Type (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Chemotherapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Targeted Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate of Hormonal Therapy (2017-2022)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2017-2022)
Table Global Oncology/Cancer Drugs Consumption by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Market Share by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Retail Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Online Pharmacies (2017-2022)
Table Global Oncology/Cancer Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Oncology/Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncology/Cancer Drugs Price and Trend Forecast (2022-2027)
Figure USA Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncology/Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncology/Cancer Drugs Market Sales Volume Forecast, by Type
Table Global Oncology/Cancer Drugs Sales Volume Market Share Forecast, by Type
Table Global Oncology/Cancer Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Oncology/Cancer Drugs Revenue Market Share Forecast, by Type
Table Global Oncology/Cancer Drugs Price Forecast, by Type
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Targeted Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2022-2027)
Figure Global Oncology/Cancer Drugs Revenue (Million USD) and Growth Rate of Hormonal Therapy (2022-2027)
Table Global Oncology/Cancer Drugs Market Consumption Forecast, by Application
Table Global Oncology/Cancer Drugs Consumption Market Share Forecast, by Application
Table Global Oncology/Cancer Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Oncology/Cancer Drugs Revenue Market Share Forecast, by Application
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Retail Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Online Pharmacies (2022-2027)
Figure Global Oncology/Cancer Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Oncology/Cancer Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure AstraZeneca PLC Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc. Profile
Table AbbVie Inc. Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc. Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure AbbVie Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson (Janssen Global Services, LLC) Profile
Table Johnson & Johnson (Janssen Global Services, LLC) Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson (Janssen Global Services, LLC) Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson (Janssen Global Services, LLC) Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Oncology/Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Oncology/Cancer Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
